US Patent Family Members and Approved Drugs for Spain Patent: 2243721
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Spain Patent: ES2243721
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| ⤷ Get Started Free | 2021-01-05 | somatropin | Novo Nordisk Inc. | NORDITROPIN |
| ⤷ Get Started Free | 2021-01-05 | insulin degludec and insulin aspart | Novo Nordisk Inc. | RYZODEG 70/30 |
| ⤷ Get Started Free | 2021-01-05 | insulin aspart | Novo Nordisk Inc. | NOVOLOG |
| ⤷ Get Started Free | 2021-01-05 | insulin detemir | Novo Nordisk Inc. | LEVEMIR |
| ⤷ Get Started Free | 2021-01-05 | insulin degludec | Novo Nordisk Inc. | TRESIBA |
| ⤷ Get Started Free | 2021-01-05 | insulin degludec and insulin aspart | Novo Nordisk Inc. | RYZODEG 70/30 |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
